Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Devlin

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search InitiationEric Davis, Sean Devlin, Candice Cooper, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experienceGerald A Soff, Jodi Mones, Cy Wilkins, et al.
Leukemia & Lymphoma|July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot studySham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Blood|September 4, 2014
Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practiceDuncan Purtill, Katherine Smith, Sean Devlin, et al.
Blood|June 26, 2014
A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myelomaNikoletta Lendvai, Patrick Hilden, Sean Devlin, et al.
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Journal of the Advanced Practitioner in Oncology|April 3, 2023
Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective ReviewTheresa A Elko, Samantha Brown, Stephanie Lobaugh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2013
"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftmentParastoo B Dahi, Doris M Ponce, Sean Devlin, et al.
Leukemia & Lymphoma|October 14, 2016
Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiencyAdebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search InitiationEric Davis, Sean Devlin, Candice Cooper, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experienceGerald A Soff, Jodi Mones, Cy Wilkins, et al.
Leukemia & Lymphoma|July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot studySham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Blood|September 4, 2014
Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practiceDuncan Purtill, Katherine Smith, Sean Devlin, et al.
Blood|June 26, 2014
A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myelomaNikoletta Lendvai, Patrick Hilden, Sean Devlin, et al.
Bone Marrow Transplantation|September 21, 2022
Management of prolonged cytopenia following CAR T-cell therapyMagdalena Corona, Roni Shouval, Ana Alarcón, et al.
Journal of the Advanced Practitioner in Oncology|April 3, 2023
Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective ReviewTheresa A Elko, Samantha Brown, Stephanie Lobaugh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2013
"No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftmentParastoo B Dahi, Doris M Ponce, Sean Devlin, et al.
Leukemia & Lymphoma|October 14, 2016
Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiencyAdebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, et al.
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
Pageof 8